The DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Oxidative stress promotes myofibroblast differentiation and tumour spreading
Open accessAbstract
JunD regulates genes involved in antioxidant defence. We took advantage of the chronic oxidative stress resulting from junD deletion to examine the role of reactive oxygen species (ROS) in tumour development. In a model of mammary carcinogenesis, junD inactivation increased tumour incidence and revealed an associated reactive stroma. junD-inactivation in the stroma was sufficient to shorten tumour-free survival rate and enhance metastatic spread. ROS promoted conversion of fibroblasts into highly migrating myofibroblasts through accumulation of the hypoxia-inducible factor (HIF)-1alpha transcription factor and the CXCL12 chemokine. Accordingly, treatment with an antioxidant reduced the levels of HIF and CXCL12 and numerous myofibroblast features. CXCL12 accumulated in the stroma of HER2-human breast adenocarcinomas. Moreover, HER2 tumours exhibited a high proportion of myofibroblasts, which was significantly correlated to nodal metastases. Interestingly, this subset of tumours exhibited a significant nuclear exclusion of JunD and revealed an associated oxido-reduction signature, further demonstrating the relevance of our findings in human cancers. Collectively, our data uncover a new mechanism by which oxidative stress increases the migratory properties of stromal fibroblasts, which in turn potentiate tumour dissemination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CAFs and ROS engage in two-way cross-talk: on the one hand, fibroblasts are targeted by ROS, particularly H2O2, which is able to convert them into active CAFs through the upregulation of HIF1α; on the other hand, CAFs are critical for the increase in ROS levels observed in cancer50,51.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,354
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1782 · Cited by 2,299
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1477 · Cited by 1,817
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Ömeroğlu, G., Meterissian, S. H., Ömeroğlu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,707
Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 1×
“…that HER2-breast tumours reveal a high content of various collagens, when compared to BLC. Interestingly, imaging of invading co-cultures of squamous cell carcinoma with stromal fibroblasts revealed that the leading cell is 2010 EMBO Molecular Medicine always a fibroblast (Gaggioli et al, 2007).”
BackgroundErez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515
A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., & Springer, T. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1101 · Cited by 1,482
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
Collagen density promotes mammary tumor initiation and progression
Provenzano, P. P., Inman, D. R., Eliceiri, K. W., Knittel, J. G., Yan, L., Rueden, C., White, J. G., & Keely, P. J. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-11 · Cited by 1,394
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Baselga, J. M., & Swain, S. M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2656 · Cited by 1,170
Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
Hwang, R. F., Moore, T. T., Arumugam, T., Ramachandran, V., Amos, K. D., Rivera, A. M., Ji, B., Evans, D. B., & Logsdon, C. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5714 · Cited by 1,117
A global test for groups of genes: testing association with a clinical outcome
Goeman, J. J., van de Geer, S., de Kort, F., & van Houwelingen, H. C. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btg382 · Cited by 1,052
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT
Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 1,006
Chang, H. Y., Nuyten, D. S. A., Sneddon, J. B., Hastie, T., Tibshirani, R., Sørlie, T., Dai, H., He, Y. D., van't Veer, L. J., Bartelink, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409462102 · Cited by 981
Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., Montgomery, K. D., Chi, J., van de Rijn, M., Botstein, D., & Brown, P. O. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020007 · Cited by 957
Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells
Mishra, P. J., Mishra, P. J., Humeniuk, R., Medina, D. J., Alexe, G., Mesirov, J. P., Ganesan, S., Glod, J. W., & Banerjee, D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0943 · Cited by 912
Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M. D. G., Bekele, B. N., Champlin, R. E., & Andreeff, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh299 · Cited by 841
Sinn, E., Muller, W. J., Pattengale, P. K., Tepler, I., Wallace, R., & Leder, P. (1987) · Cell · doi:10.1016/0092-8674(87)90449-1 · Cited by 788
Parrinello, S., Coppe, J.-P., Krtolica, A., & Campisi, J. (2005) · Journal of Cell Science · doi:10.1242/jcs.01635 · Cited by 631
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Farmer, P. J., Bonnefoi, H. R., Anderle, P., Cameron, D., Wirapati, P., Becette, V., André, S., Piccart, M. J., Campone, M., Brain, E. G. C., et al. (2009) · Nature Medicine · doi:10.1038/nm.1908 · Cited by 618
JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress
Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., Pouysségur, J., Yaniv, M., & Mechta-Grigoriou, F. (2004) · Cell · doi:10.1016/j.cell.2004.08.025 · Cited by 588
Self-citationCancer-associated fibroblasts and tumor growth – bystanders turning into key players
Östman, A., & Augsten, M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.01.003 · Cited by 555
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobágyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 539
Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., & Wright, N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1708 · Cited by 530
Regulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D. R., Richardson, A. L., Violette, S. M., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 513
Pten in stromal fibroblasts suppresses mammary epithelial tumours
Trimboli, A. J., Cantemir-Stone, C. Z., Li, F., Wallace, J. A., Merchant, A. S., Creasap, N., Thompson, J. C., Caserta, E., Wang, H., Chong, J.-L., et al. (2009) · Nature · doi:10.1038/nature08486 · Cited by 507
Inflammation and oncogenesis: a vicious connection
Grivennikov, S. I., & Karin, M. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.004 · Cited by 474
Rønnov‐Jessen, L., PETERSEN, O. W., Koteliansky, V., & Bissell, M. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117736 · Cited by 443
De Wever, O., Nguyen, Q., Van Hoorde, L., Bracke, M., Bruyneel, E., Gespach, C., & Mareel, M. (2004) · The FASEB Journal · doi:10.1096/fj.03-1110fje · Cited by 402 · cited 1×
“Moreover, in vitro co-cultures of myofibroblasts and tumour epithelial cells demonstrated that myofibroblasts promote invasion of breast, colon, pancreas and squamous carcinoma cells (Casey et al, 2008; De Wever et al, 2004; Hwang et al, 2008; Lewis et al, 2004).”
BackgroundMORI, L., BELLINI, A., Stacey, M. A., Schmidt, M., & Mattoli, S. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.11.011 · Cited by 382
Stromal Myofibroblasts Predict Disease Recurrence for Colorectal Cancer
辻野, 督., Seshimo, I., Yamamoto, H., Ngan, C. Y., Ezumi, K., Takemasa, I., Ikeda, M., Sekimoto, M., Matsuura∥, N., & Monden, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2191 · Cited by 353
Fibrosis and cancer: Do myofibroblasts come also from epithelial cells via EMT?
Radisky, D. C., Kenny, P. A., & Bissell, M. J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21186 · Cited by 352
The mammalian Jun proteins: redundancy and specificity
Mechta‐Grigoriou, F., Gerald, D., & Yaniv, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204381 · Cited by 340
Self-citationStroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Kryczek, I., Wei, S., Keller, E. T., Liu, R., & Zou, W. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00406.2006 · Cited by 337
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 1×
“MMP3 was also defined as a major factor secreted from senescent fibroblasts (Parrinello et al, 2005), which constitute an inflammatory environment that compromises the structure and the functions of the surrounding tissue (Coppe et al, 2008).”
BackgroundQiu, W., Hu, M., Sridhar, A., Opeskin, K., Fox, S. B., Shipitsin, M. V., Trivett, M. K., Thompson, E. R., Ramakrishna, M., Gorringe, K. L., et al. (2008) · Nature Genetics · doi:10.1038/ng.117 · Cited by 287
Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction
Ishii, G., Sangai, T., Oda, T., Aoyagi, Y., Hasebe, T., Kanomata, N., Endoh, Y., Okumura, C., Okuhara, Y., Magae, J., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01544-4 · Cited by 281
Lewis, M. P., Lygoe, K. A., Nystrom, M. L., Anderson, W., Speight, P. M., Marshall, J. F., & Thomas, G. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601611 · Cited by 266
Vleugel, M. M., Greijer, A. E., Shvarts, A., van der Groep, P., van Berkel, M., Aarbodem, Y., van Tinteren, H., Harris, A. L., van Diest, P. J., & van der Wall, E. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.019885 · Cited by 227
Transformation by ras modifies AP1 composition and activity
Mechta‐Grigoriou, F., Lallemand, D., Pfarr, C. M., & Yaniv, M. (1997) · Oncogene · doi:10.1038/sj.onc.1200900 · Cited by 212
Self-citationMechanisms of Disease: fibroblasts—a new look at an old problem
Neilson, E. G. (2006) · Nature Reviews Nephrology · doi:10.1038/ncpneph0093 · Cited by 199
Determination of Stromal Signatures in Breast Carcinoma
West, R. B., Nuyten, D. S. A., Subramanian, S., Nielsen, T. O., Corless, C. L., Rubin, B. P., Montgomery, K. D., Zhu, S., Patel, R. M., Hernandez‐Boussard, T., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030187 · Cited by 194
Müller, L. P., Goumas, F. A., Affeldt, M., Sandtner, S., Gehling, U. M., Brilloff, S., Walter, J., Karnatz, N., Lamszus, K., Rogiers, X., et al. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060661 · Cited by 189
Redox regulation of the hypoxia-inducible factor
Pouysségur, J., & Mechta-Grigoriou, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.167 · Cited by 186 · cited 1×
“In consequence, HIF-a proteins accumulate and enhance transcription of specific target genes such as VEGF-A (Pouyssegur & Mechta-Grigoriou, 2006).”
BackgroundSelf-citationInflammation, proteases and cancer
van Kempen, L. C. L. T., de Visser, K. E., & Coussens, L. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.004 · Cited by 181
Francis, P., Namløs, H. M., Müller, C., Edén, P., Fernebro, J., Berner, J., Bjerkehagen, B., Åkerman, M., Bendahl, P., Isinger-Ekstrand, A., et al. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-73 · Cited by 169
Preston, T. J., Muller, W. J., & Singh, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004617200 · Cited by 152
Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer
Yamamoto, Y., Ibusuki, M., Okumura, Y., Kawasoe, T., Kai, K., Iyama, K., & Iwase, H. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9742-1 · Cited by 151
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Gruber, G., Greiner, R. H., Hlushchuk, R., Aebersold, D. M., Altermatt, H. J., Berclaz, G., & Djonov, V. (2004) · Breast Cancer Research · doi:10.1186/bcr775 · Cited by 148
Epithelial-Mesenchymal Transition
Zavadil, J., Haley, J. D., Kalluri, R., Muthuswamy, S. K., & Thompson, E. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2316 · Cited by 144
The Gα13-Rho Signaling Axis Is Required for SDF-1-induced Migration through CXCR4
Tan, W., Martı́n, D., & Gutkind, J. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609062200 · Cited by 141
New insights on the role of CXCR4 in cancer metastasis
Zlotnik, A. (2008) · The Journal of Pathology · doi:10.1002/path.2350 · Cited by 140
Bartolomé, R. A., Gálvez, B. G., Longo, N., Baleux, F., van Muijen, G. N. P., Sánchez‐Mateos, P., Arroyo, A. G., & Teixidó, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3398 · Cited by 137
The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer
Kang, H., Watkins, G., Douglas-Jones, A. G., Mansel, R. E., & Jiang, W. G. (2005) · The Breast · doi:10.1016/j.breast.2004.12.007 · Cited by 133
Casey, T. M., Eneman, J., Crocker, A., White, J., Tessitore, J., Stanley, M., Harlow, S., Bunn, J. Y., Weaver, D., Muss, H., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9684-7 · Cited by 127
Oxidants in Receptor Tyrosine Kinase Signal Transduction Pathways
Aslan, M., & Özben, T. (2003) · Antioxidants and Redox Signaling · doi:10.1089/152308603770380089 · Cited by 125
Stromal induction of breast cancer: Inflammation and invasion
Radisky, E. S., & Radisky, D. C. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9037-1 · Cited by 125
Coevolution of cancer and stromal cellular responses
Littlepage, L. E., Egeblad, M., & Werb, Z. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.019 · Cited by 125
The myofibroblast and its tumours
Eyden, B. P., Banerjee, S. S., Shenjere, P., & Fisher, C. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.061630 · Cited by 122
Origin of carcinoma associated fibroblasts
Haviv, I., Polyák, K., Qiu, W., Hu, M., & Campbell, I. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7669 · Cited by 118
c-MET Expression in Myofibroblasts
Tokunou, M., Niki, T., Eguchi, K., Iba, S., Tsuda, H., Yamada, T., Matsuno, Y., Kondo, H., Saitoh, Y., Imamura, H., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64096-5 · Cited by 113
The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis
Gelmini, S., Mangoni, M., Serio, M., Romagnani, P., & Lazzeri, E. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03349262 · Cited by 107
Yazhou, C., Wenlv, S., Zhang, W., & Wu, L. (2004) · Tumor Biology · doi:10.1159/000081394 · Cited by 98
c- erb B-2 Related Aggressiveness in Breast Cancer Is Hypoxia Inducible Factor-1α Dependent
Giatromanolaki, A. N., Koukourakis, M. I., Simopoulos, C., Polychronidis, A., Gatter, K. C., Harris, A. L., & Sivridis, E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1068 · Cited by 81
Oxidative Stress Contributes to Aging by Enhancing Pancreatic Angiogenesis and Insulin Signaling
Laurent, G., Solari, F., Mateescu, B., Karaca, M., Castel, J., Bourachot, B., Magnan, C., Billaud, M., & Mechta‐Grigoriou, F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.010 · Cited by 76
Self-citationDaly, A. J., McIlreavey, L., & Irwin, C. R. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.08.012 · Cited by 75
Wang, X., Witting, P. K., Salvatore, B. A., & Neužil, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.028 · Cited by 73
Hematopoietic origins of fibroblasts: I. In vivo studies of fibroblasts associated with solid tumors
LaRue, A. C., Masuya, M., Ebihara, Y., Fleming, P. A., Visconti, R. P., Minamiguchi, H., Ogawa, M., & Drake, C. J. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2005.10.009 · Cited by 73
Bartlett, J. M. S., Ellis, I. O., Dowsett, M., Mallon, E., Cameron, D., Johnston, S. R. D., Hall, E., A’Hern, R., Peckitt, C., Bliss, J. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.0973 · Cited by 67
Genomic Alterations in Tumor Stroma
Eng, C., Leone, G. W., Orloff, M. S., & Ostrowski, M. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0985 · Cited by 57
A Mouse Stromal Response to Tumor Invasion Predicts Prostate and Breast Cancer Patient Survival
Bacac, M., Provero, P., Mayran, N., Stehle, J., Fusco, C., & Stamenkovic, I. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000032 · Cited by 55
Nguyen, Q., Wever, O. D., Bruyneel, E. A., Hendrix, A., Xie, W., Lombet, A., Leibl, M., Mareel, M. M. K., Gieseler, F., Bracke, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208990 · Cited by 49
A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction
Timp, W., Levchenko, A., & Feinberg, A. P. (2009) · Cell Cycle · doi:10.4161/cc.8.3.7542 · Cited by 32
Cited by
Sorted by citations
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
ROS in cancer therapy: the bright side of the moon
Perillo, B., Di Donato, M., Pezone, A., Di Zazzo, E., Giovannelli, P., Galasso, G., Castoria, G., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0384-2 · Cited by 2,176
Turning foes to friends: targeting cancer-associated fibroblasts
Chen, X., & Song, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0004-1 · Cited by 1,929
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705
Self-citationThe role of ROS in tumour development and progression
Cheung, E. C., & Vousden, K. H. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-021-00435-0 · Cited by 1,663
Metadata
- Authors
- Toullec, A., Gerald, D., Despouy, G., Bourachot, B., Cardon, M., Lefort, S., Richardson, M., Rigaill, G., Parrini, M., Lucchesi, C., Bellanger, D., Stern, M., Dubois, T., Sastre‐Garau, X., Delattre, O., Vincent‐Salomon, A., & Mechta‐Grigoriou, F.
- Affiliations
- Inserm (FR)
- Institut Curie (FR)
- Corresponding author
- Mechta‐Grigoriou, Fatima
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2010-06-01
- Volume
- 2
- Issue
- 6
- Pages
- 211-230
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3377319
- OpenAlex
- W2107028932
- Cited by
- 339
- References
- 91
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 27 · 2023: 38 · 2022: 33 · 2021: 30 · 2020: 23 · 2019: 12 · 2018: 11 · 2017: 17 · 2016: 14 · 2015: 13 · 2014: 19 · 2013: 22 · 2012: 22
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- EMBO Molecular Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Institut Curie
- Fondation de France
- Agence Nationale de la Recherche
- French National Institut of Cancer
- Association pour la Recherche contre le Cancer
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- oxidative stress, JunD, myofibroblast differentiation, tumour metastasis, reactive oxygen species, mammary carcinogenesis, stromal fibroblasts, HIF-1α, CXCL12, HER2-positive breast cancer, antioxidant therapy, tumor microenvironment, hypoxia
- MeSH terms
- Animals, Breast Neoplasms, Cell Differentiation, Cell Line, Female, Fibroblasts, Histocytochemistry, Humans, Immunohistochemistry, Locomotion, Microscopy, Microscopy, Fluorescence, Models, Biological, Neoplasm Metastasis, Proto-Oncogene Proteins, Mammary Neoplasms, Animal, Incidence, Survival Analysis, Proto-Oncogene Proteins c-jun, Reactive Oxygen Species, Mice, Knockout, Oxidative Stress, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Chemokine CXCL12
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
